SANUWAVE Health Reports Director Changes & Officer Appointments
Ticker: SNWV · Form: 8-K · Filed: Aug 20, 2025 · CIK: 1417663
| Field | Detail |
|---|---|
| Company | Sanuwave Health, Inc. (SNWV) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, governance, filing
TL;DR
SANUWAVE leadership shake-up: new directors elected, officers appointed, and compensation details disclosed.
AI Summary
SANUWAVE Health, Inc. filed an 8-K on August 20, 2025, reporting on several key events. These include the departure of directors or certain officers, the election of new directors, the appointment of certain officers, and details regarding compensatory arrangements for these officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing indicates significant changes in the company's leadership and governance structure, which could impact strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in board and officer composition can signal strategic shifts or internal challenges, requiring investor attention.
Key Players & Entities
- SANUWAVE Health, Inc. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- 201176000 (tax_id) — IRS Employer Identification No.
- August 19, 2025 (date) — Date of earliest event reported
- August 20, 2025 (date) — Date of report
FAQ
Who has departed from SANUWAVE Health, Inc.'s board or officer positions?
The filing indicates the departure of directors or certain officers, but specific names are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 19, 2025.
What is the company's state of incorporation?
SANUWAVE Health, Inc. is incorporated in Nevada.
What are the main topics covered in this 8-K filing?
The filing covers departure of directors/officers, election of directors, appointment of officers, compensatory arrangements, submission of matters to a vote, and financial statements/exhibits.
What is the principal executive office address for SANUWAVE Health, Inc.?
The principal executive offices are located at 9600 W. 76th Street, Suite 118, Eden Prairie, Minnesota 55344.
Filing Stats: 846 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2025-08-20 16:49:03
Key Financial Figures
- $0.001 — h registered Common stock, par value $0.001 per share SNWV The Nasdaq Stock Market
Filing Documents
- snwv-20250819.htm (8-K) — 51KB
- exhibit101.htm (EX-10.1) — 139KB
- 0001628280-25-040914.txt ( ) — 322KB
- snwv-20250819.xsd (EX-101.SCH) — 2KB
- snwv-20250819_lab.xml (EX-101.LAB) — 19KB
- snwv-20250819_pre.xml (EX-101.PRE) — 11KB
- snwv-20250819_htm.xml (XML) — 2KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On August 19, 2025, the Company held its 2025 annual meeting of stockholders. The following matters (the "Proposals") were voted upon by the stockholders with the final voting results as shown: Proposal 1. To elect five directors, Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller and James Tyler, to serve until the 2026 annual meeting of stockholders. Name Votes For Withheld Broker Non-Votes Morgan Frank 5,160,671 9,229 850,909 Gregory Bazar 5,168,313 1,587 850,909 Jeffrey Blizard 5,050,443 119,457 850,909 Ian Miller 4,703,248 466,652 850,909 James Tyler 4,936,933 232,967 850,909 Proposal 2. To ratify the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. Votes For Votes Against Abstain Broker Non-Votes 6,017,993 1,473 1,343 – Proposal 3. To approve an amendment to the SANUWAVE Health, Inc. 2024 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 500,000 shares. Votes For Votes Against Abstain Broker Non-Votes 4,948,127 202,867 18,906 850,909 Proposal 4. To approve, in an advisory, non-binding vote, the compensation paid to the Company's named executive officers. Votes For Votes Against Abstain Broker Non-Votes 5,136,449 30,601 2,850 850,909 Proposal 5. To approve, in an advisory, non-binding vote, the frequency of future votes on the compensation paid to the Company's named executive officers. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 5,157,469 1,987 5,121 5,323 850,909 The Proposals, which are described in more detail in the Proxy Statement, received the affirmative requisite vote of the stockholders of the Company. 2
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 SANUWAVE Health, Inc. 2024 Equity Incentive Plan, as amended August 19, 2025. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document. 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SANUWAVE HEALTH, INC. Dated: August 20, 2025 By: /s/ Morgan C. Frank Name: Morgan C. Frank Title: Chief Executive Officer 4